3.0.0 7722 2023-01-11T13:45:52Z 2023-01-11T13:45:52Z House HR 2020-07-22 116 [Congressional Record Volume 166, Number 129 (Wednesday, July 22, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. FORTENBERRY:H.R. 7722.Congress has the power to enact this legislation pursuantto the following:The constitutional authority for this bill is pursuant toArticle I, Section 8, Clause 18 of the United StatesConstitution.[Page H3693]]]> hsed00 Education and the Workforce Committee House Standing Referred to 2020-07-22T13:00:15Z hsif00 Energy and Commerce Committee House Standing Referred to 2020-07-22T13:00:10Z 2020-07-22 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsed00 Education and the Workforce Committee 2020-07-22 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-07-22 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-07-22 Introduced in House IntroReferral 1000 9 Library of Congress F000449 Rep. Fortenberry, Jeff [R-NE-1] Jeff Fortenberry R NE 1 N C001119 Rep. Craig, Angie [D-MN-2] Angie Craig D MN 2 2020-07-22 True Health Business records Congressional oversight Digestive and metabolic diseases Drug therapy Health care costs and insurance Health care coverage and access Inflation and prices Prescription drugs Health 00 2020-07-22 Introduced in House 2022-04-18T15:43:03Z Matt's Act

This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge an uninsured individual who has diabetes the average net price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.

]]> Matt’s Act Display Title Matt’s Act Short Title(s) as Introduced Matt’s Act Introduced in House IH Official Title as Introduced To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and group health plans and for uninsured individuals who have diabetes, and for other purposes. Introduced in House IH Introduced in House 2020-07-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr7722ih/xml/BILLS-116hr7722ih.xml 2020-07-22 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.